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Elongation factor P (EF-P) is a ubiquitous translation factor that facilitates
translation of polyproline motifs. In order to perform this function, EF-P generally requires posttranslational modiﬁcation (PTM) on a conserved residue. Although the position of the modiﬁcation is highly conserved, the structure can vary widely between organisms. In Bacillus subtilis, EF-P is modiﬁed at Lys32 with a 5-aminopentanol moiety.
Here, we use a forward genetic screen to identify genes involved in 5-aminopentanolylation.
Tandem mass spectrometry analysis of the PTM mutant strains indicated that ynbB,
gsaB, and ymfI are required for modiﬁcation and that yaaO, yfkA, and ywlG inﬂuence
the level of modiﬁcation. Structural analyses also showed that EF-P can retain
unique intermediate modiﬁcations, suggesting that 5-aminopentanol is likely directly
assembled on EF-P through a novel modiﬁcation pathway. Phenotypic characterization of these PTM mutants showed that each mutant does not strictly phenocopy
the efp mutant, as has previously been observed in other organisms. Rather, each
mutant displays phenotypic characteristics consistent with those of either the efp
mutant or wild-type B. subtilis depending on the growth condition. In vivo polyproline reporter data indicate that the observed phenotypic differences result from variation in both the severity of polyproline translation defects and altered EF-P context
dependence in each mutant. Together, these ﬁndings establish a new EF-P PTM
pathway and also highlight a unique relationship between EF-P modiﬁcation and
polyproline context dependence.

ABSTRACT
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Despite the high level of conservation of EF-P, the posttranslational
modiﬁcation pathway that activates EF-P is highly divergent between species. Here,
we have identiﬁed and characterized in B. subtilis a novel posttranslational modiﬁcation pathway. This pathway not only broadens the scope of potential EF-P modiﬁcation strategies, but it also indicates that EF-P modiﬁcations can be assembled directly on EF-P. Furthermore, characterization of these PTM mutants has established
that an altered modiﬁcation state can impact both the severity of polyproline translational defects and context dependence.
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D

uring translation, the ribosome employs aminoacyl-tRNAs and a number of translation factors in order to decode an mRNA and synthesize a polypeptide. The rate
of translation can depend on a number of factors such as codon usage, mRNA structure,
and amino acid structure (1, 2). For example, proline has a unique pyrrolidine ring
structure that creates signiﬁcant steric constraints, making proline both a poor peptidyl
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acceptor and donor (3). Due to this limitation, translation of polyproline can be
substantially slower than translation of other amino acid motifs and often results in
translational pausing (4, 5). In order to alleviate polyproline-induced translational
pausing, a universally conserved translation factor, elongation factor P (EF-P) (eukaryotic initiation factor 5A [eIF5A] in eukaryotes and archaeal initiation factor 5A [aIF5A] in
archaea) binds the ribosome between the P and E sites and entropically stimulates
peptide bond formation (6–11).
In order to stimulate translation of polyproline motifs, EF-P requires posttranslational modiﬁcation (PTM) at a highly conserved residue (12, 13). The structure of the
modiﬁcation can vary substantially between organisms. In eukaryotes, deoxyhypusine
synthase (DHS) and deoxyhypusine hydroxylase (DOHH) coordinately modify the EF-P
homolog eIF5A with a hypusine moiety, and hypusinated eIF5A is essential for viability
(14). In Pseudomonas aeruginosa and Neisseria meningitidis, EF-P is modiﬁed by EarP
with a rhamnose moiety. Loss of EF-P or EarP can cause severe growth defects or, in
some cases, lethality (15–17). In Escherichia coli and Salmonella enterica, EpmA, EpmB,
and EpmC modify EF-P with R-␤-lysine (18–20). Although R-␤-lysylated EF-P is not
required for viability, mutants display a wide range of pleiotropic phenotypic characteristics, including growth defects and loss of virulence (20, 21). Recently, the search for
EF-P PTMs has been expanded to Gram-positive bacteria. In Bacillus subtilis, EF-P is
modiﬁed with a 5-aminopentanol moiety at Lys32 (22). However, in B. subtilis, loss of
EF-P does not result in the severe viability and growth defects observed in other
bacteria. Instead, the major requirement for EF-P in B. subtilis is for swarming motility
(22, 23).
We have recently shown that YmfI reduces 5-aminopentanone to 5-aminopentanol
in the ﬁnal step of EF-P modiﬁcation (24). Further, we showed that 5-aminopentanone,
but not unmodiﬁed EF-P, is inhibitory to swarming motility, as abolishing posttranslational modiﬁcation of EF-P altogether by mutation of Lys32 to an arginine suppressed
the ymfI swarming defect (24). Here, we take advantage of EF-P activity in the absence
of modiﬁcation to identify other enzymes that act upstream of YmfI in the EF-P
modiﬁcation pathway (24). Mass spectrometry analyses of EF-P puriﬁed from wild-type
(WT) B. subtilis and each of the modiﬁcation mutants revealed that EF-P can retain
incomplete modiﬁcations. In order to investigate the physiological consequences of
producing EF-P with an intermediate modiﬁcation, we phenotypically characterized
these mutants for swarming proﬁciency and antibiotic resistance. By using this screen,
we observed that PTM mutants display phenotypic characteristics similar to those of an
efp mutant under some growth conditions, but not others. In vivo polyproline reporter
data revealed that this phenotypic discrepancy is due to variability in polyproline
translation defect severity and context dependence in each mutant. Together, these
results establish the 5-aminopentanol modiﬁcation pathway and reveal a relationship
between EF-P modiﬁcation and motif-speciﬁc EF-P dependence.
RESULTS
A forward genetic screen to identify genes required for modiﬁcation of EF-P.
We have previously shown that, in the absence of YmfI, EF-P accumulates an intermediate modiﬁcation on Lys32 that is inhibitory for swarming motility (24). One way to
bypass this inhibition was to prevent posttranslational modiﬁcation of EF-P through
mutation of the modiﬁcation site, Lys32, to an arginine (24). We hypothesized that
another way to bypass inhibition was to abolish posttranslational modiﬁcation of EF-P
through deletion of enzymes required for modiﬁcation. A nonswarming ymfI efp (efp⫹)
sensitized mutant background was transposon mutagenized in 26 parallel replicates,
approximately 10,000 colonies were separately combined to form each pool, and the 26
separate pools were used to inoculate swarm agar. After a prolonged lag period, a
subpopulation of cells were able to move out from the site of inoculation of each pool.
One swarming proﬁcient clone from each pool was isolated and backcrossed to the
ymfI efp (efp⫹) parent by SPP1-mediated phage transduction. Each transposon insertion
improved swarming motility, suggesting that the transposon was linked to the pheMarch/April 2018 Volume 9 Issue 2 e00306-18
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FIG 1 Deletion of gsaB, ynbB, yaaO, yfkA, or ywlG suppresses the swarming defect of a ymfI mutant. A quantitative swarm
expansion assay was used in which mid-log-phase cultures were used to inoculate swarm plates. The swarm radius was
monitored along the same axis every 30 min for 6 h. Data points represent the average values for three technical replicates.
In panel D, swarm plates were supplemented with 1 mM IPTG. The strains with the indicated genotype were used as the
inoculum in the different panels: (A) WT (DK1042), efp (DK2050), and ymfI (DK3621); (B) gsaB ymfI (DK5171) and gsaB ymfI
(gsaB) (DK5320); (C) ynbB ymfI (DK5172) and ynbB ymfI (ynbB) (DK5321); (D) yaaO ymfI (DK4077) and yaaO ymfI (yaaO)
(DK5328); (E) yfkA ymfI (DK5170) and yfkA ymfI (yfkA) (DK5304); (F) ywlG ymfI (DK5174) and ywlG ymfI (ywlG) (DK5326); (G)
ynbA ymfI (DK5173) and ynbA ymfI (ynbA) (DK5322); (H) ynbA::Tn ymfI (DK5339) and ynbA::Tn ymfI (ynbB) (DK5340); (I) gsaB
(DK4601), gsaB (gsaB) (DK5308), ynbB (DK4604), and ynbB (ynbB) (DK5309).

notype and suppressed the swarming defect of the ymfI mutation alone (see Fig. S1A
in the supplemental material). The locations of the transposons were determined by
inverse PCR.
Of the 26 transposon insertion suppressors of ymfI, 9 had a mutation in gsaB, 8 had
a mutation in the ynbAB operon, 7 had a mutation in yaaO, 1 had a mutation in yfkA,
and 1 had a mutation in ywlG (Table S1). To determine whether each gene disrupted
by the transposon insertions was directly responsible for the phenotype, gsaB, ynbA,
ynbB, yaaO, yfkA, and ywlG, were disrupted by in-frame markerless deletion. Deletion of
gsaB, ynbB, yaaO, yfkA, and ylwG increased swarming of the ymfI mutant, but deletion
of ynbA did not (Fig. 1A to G). The gsaB, ynbB, yfkA, and ywlG deletion mutants could
each be complemented by integrating a construct containing the corresponding gene
cloned downstream of the putative native promoter at the ectopic amyE site in the
March/April 2018 Volume 9 Issue 2 e00306-18
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FIG 2 Lysates from WT (DK1042), ymfI (DK3621), yaaO (DK3894), gsaB (DK4601), ynbB (DK4604), yfkA
(DK4564), and ywlG (DK4612) strains were resolved via isoelectric focusing. Puriﬁed recombinant EF-P
(rEF-P) was run as an unmodiﬁed control. Blots were probed with anti-EF-P polyclonal antisera.

chromosome (Fig. 1A to C, E, and F). While the yaaO deletion mutant could not be
complemented by cloning yaaO expressed from its putative native promoter, it was
complemented when yaaO was expressed under the control of an isopropyl-␤-Dthiogalactopyranoside (IPTG)-inducible promoter (Fig. S1B and Fig. 1D). We infer that
suppression of the ymfI swarming defect was caused by deletion of gsaB, ynbB, yaaO,
yfkA, and ywlG rather than polar effects caused by the transposon insertion. In contrast,
transposon insertions in ynbA were likely polar on ynbB, as swarming motility inhibition
was restored to the transposon mutants when the ynbB complementation construct
was ectopically integrated (Fig. 1H). We conclude that deletion of gsaB, yaaO, ynbB,
yfkA, or ywlG, but not ynbA, suppresses the ymfI mutant swarming defect.
To determine whether the identiﬁed genes impact posttranslational modiﬁcation of
EF-P, each single deletion strain was screened for EF-P electrophoretic mobility by
isoelectric focusing and seminative gel electrophoresis. In isoelectric focusing, EF-P in
wild-type (WT) B. subtilis cells resolved as one band. EF-P in the yfkA, ynbB, gsaB, and
yaaO mutants migrated as one band with an isoelectric focusing point lower than that
of wild-type EF-P, suggesting an alteration in modiﬁcation state (Fig. 2). Unlike the
other mutants, EF-P from the ywlG and ymfI mutants migrated as two bands (Fig. 2). In
seminative gel electrophoresis, EF-P resolved as two bands in the wild-type background
(Fig. S2). In each of the mutant strains, except the ywlG mutant, EF-P resolved as one
band with an electrophoretic mobility similar to that of the lower band in the wild-type
strain (Fig. S2). We infer that mutations that restore swarming in the absence of YmfI
alter EF-P electrophoretic mobility and may do so by different mechanisms.
Mutants that suppress the absence of YmfI display aberrant 5-aminopentanolylation. In order to determine the modiﬁcation status of EF-P in the absence of GsaB,
YaaO, YnbB, YfkA, or YwlG, FLAG-tagged EF-P (EF-P-FLAG) was overexpressed and afﬁnity
tag puriﬁed from each mutant background, in-gel digested with trypsin, and then resolved
in an Orbitrap Elite or Orbitrap Fusion mass spectrometer. In tandem mass spectrometry
(MS/MS) analyses, the most abundant ions were selected for electron transfer dissociation
(ETD). In the wild-type control, ions corresponding to unmodiﬁed EF-P (m/z ⫽ 314.181; z ⫽
4⫹), as well as 5-aminopentanolylated EF-P (m/z ⫽ 489.785; z ⫽ 4⫹), with an additional
mass of 101.084 Da on Lys32 were identiﬁed (Table 1 and Fig. S3A and B). Furthermore,
additional masses on Lys32 of 82.042 (C5H7O) and 100.052 (C5H9O2) were also identiﬁed in
the wild-type strain (Table 1 and Fig. S3C and D). Given the structure of 5-aminopentanol
and its precursor, 5-aminopentanone, it is likely that the additional mass of 82.042 corresponds to pentenone and that 100.052 corresponds to hydroxypentanone.
In an effort to assign each enzyme to a step in 5-aminopentanolylation, we searched
for all identiﬁed intermediates in each mutant data set and in the ymfI data set (24). In
the ynbB and gsaB mutants, 5-aminopentanol was not detected on Lys32 (Fig. S3E and
S3G). However, in the absence of ynbB and gsaB, Lys32 was acetylated (Table 1 and
Fig. S3F and S3H). Reanalysis of the MS/MS data for the ymfI mutant (24) identiﬁed
pentenone, but not hydroxypentanone or acetylation (Table 1 and Fig. S3I). We propose
that deletion of ymfI restricts the completion of modiﬁcation leading to the accumulation of intermediates immediately upstream of 5-aminopentanone. This is consistent
with pentenone synthesis immediately preceding 5-aminopentanone reduction in the
EF-P modiﬁcation pathway. In the absence of yaaO, yfkA, and ywlG, Lys32 retained low
levels of 5-aminopentanol, indicating that these genes are not strictly required for
5-aminopentanolylation (Table 1 and Fig. S3J and K, S3M and N, S3P and Q). Acetylation
March/April 2018 Volume 9 Issue 2 e00306-18
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TABLE 1 Modiﬁcations identiﬁed on Lys32
Strain

Mass change

Chemical or modiﬁcation

WT

101.084

5-Aminopentanol

100.052

Hydroxypentanone

82.042

Pentenone

99.068

5-Aminopentanone

82.042

Pentenone

ynbB

42.011

Acetylation

gsaB

42.011

Acetylation

yaaO

101.084

5-Aminopentanol

42.011

Acetylation

101.084

5-Aminopentanol

42.011

Acetylation

101.084

5-Aminopentanol

42.011

Acetylation

ymfI

yfkA

ywlG

Proposed structure

could also be identiﬁed on Lys32 in each of these mutants (Table 1 and Fig. S3L, S3O,
and S3R).
The presence of 5-aminopentanol on Lys32 in the absence of yaaO, yfkA, and ywlG
indicates that these genes are not essential for modiﬁcation. Although the experimental design here did not allow for precise quantitative analysis, it is evident in the
extracted ion chromatograms for the unmodiﬁed and modiﬁed peptides that the level
of modiﬁcation is substantially lower in the absence of each of these genes (Fig. S4).
This together with isoelectric focusing data of the native protein (Fig. 2) suggests that
March/April 2018 Volume 9 Issue 2 e00306-18
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while these genes are not essential for modiﬁcation, they do inﬂuence it, potentially
through synthesis of the initial precursor. It has previously been observed that low
levels of EF-P modiﬁcation can be achieved through alternate metabolic routes or
environmental acquisition in the absence of canonical modiﬁcation synthesis genes
(15). The results here are consistent with yaaO, ywlG, and yfkA playing a role in synthesis
of the substrate, rather than direct modiﬁcation on EF-P itself.
In order to identify the initial substrate, we investigated the proposed activities of
PTM genes that have clear homologs with known activities. GsaB is a paralog of HemL,
a glutamate-1-semialdehyde aminotransferase that synthesizes 5-aminolevulinic acid,
and YaaO is predicted to synthesize cadaverine through lysine decarboxylation. Both
5-aminolevulinic acid and cadaverine bear striking resemblance to 5-aminopentanol.
However, supplying either of these substrates into the growth media of the yaaO and
gsaB mutants failed to restore modiﬁcation of EF-P as assessed by isoelectric focusing
(data not shown), indicating that these molecules are not the initial precursor in
5-aminopentanol formation.
5-Aminopentanol was not detected in the absence of ynbB, gsaB, and ymfI, indicating that these genes are strictly required for modiﬁcation. YmfI has previously been
shown to catalyze reduction of 5-aminopentanone to 5-aminopentanol in the ﬁnal step
of modiﬁcation (24). As acetylation was the only modiﬁcation found on Lys32 in the
absence of both ynbB and gsaB, it is difﬁcult to deﬁnitively assign each protein to a
position in the EF-P PTM pathway. On the basis of sequence similarity to genes of
known function, GsaB is predicted to have aminotransferase activity, and YnbB is
predicted to have carbon-sulfur lyase activity. On the basis of these proposed activities,
it is likely that GsaB facilitates addition of the ﬁnal amine group onto pentenone and
that YnbB removes a fatty acid biosynthesis (FAB) substrate from an acyl carrier protein
and forms hydroxypentanone on EF-P, possibly forming the ﬁrst intermediate in
5-aminopentanol formation. Although an acetyl group was identiﬁed in the PTM
mutants, the absence of this modiﬁcation in the wild-type sample suggests that it is not
a true intermediate in 5-aminopentanol formation, but rather a spurious side reaction
that occurs in the presence of high levels of unmodiﬁed EF-P. Taken together, these
data suggest a pathway for the 5-aminopentanolylation of EF-P in B. subtilis (Fig. 3).
On the basis of the proposed pathway, 5-aminopentanol is assembled directly on
EF-P in a series of dehydration/reduction reactions, a type of synthesis that resembles
fatty acid biosynthesis. Given these similarities, we hypothesized that 5-aminopentanol
is derived from FAB and that assembly could be impacted by changes in this process.
To investigate this possibility, EF-P modiﬁcation state was assessed via isoelectric
focusing after knockdown or overexpression of three essential FAB factors (fabF, fabG,
and accB) (Fig. S5) (25). Genetic manipulations of these factors did not inﬂuence the
isoelectric focusing point of EF-P, likely indicating that the FAB and PTM pathway
function independently in B. subtilis.
Phenotypic characterization of modiﬁcation mutants. Given that stable PTM
intermediates were identiﬁed in each mutant strain, it is possible that EF-P-associated
phenotypes are also altered in each of these strains. Consistent with this possibility,
swarming motility arrested prematurely in the gsaB and ynbB mutants (but not in the
yaaO, yfkA, or ywlG mutant), and both mutants could be complemented by wild-type
alleles (Fig. 1I and Fig. S1C to E). To investigate the impact of the PTM gene deletions
in alternative EF-P-associated phenotypes, growth of the WT and efp mutant were
compared in a Biolog phenotype microarray that tests for 1,920 different metabolic and
chemical sensitivities. For the majority of metabolic stressors, the WT and efp mutant
exhibited no signiﬁcant growth differences. The WT displayed relatively enhanced
respiration in 2,3-butanone (carbon source stress), and the efp mutant displayed
enhanced respiration in D-glucose-1-phosphate (organic phosphate source stress) (Table S2). Conversely, the efp mutant displayed reduced respiration under 60 different
chemical stressors with diverse mechanisms of action, indicating that EF-P activity is
required under these chemical stressors (Table 2). Many chemicals reduced the growth
March/April 2018 Volume 9 Issue 2 e00306-18
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FIG 3 Proposed modiﬁcation pathway outline based on tandem mass spectrometry analysis. Hummels
et al. (24) established that YmfI reduces 5-aminopentanone to 5-aminopentanol in the ﬁnal step of
modiﬁcation. Additional intermediates identiﬁed here represent the most likely structure based on the
structure of 5-aminopentanol.

of the efp mutant relative to the wild type, but the efp mutant grew better than the wild
type in the presence of folate biosynthesis inhibitors like sulfanilamide (Table 3). To
determine whether sulfonamide sensitivity is impacted by the EF-P modiﬁcation state,
all modiﬁcation mutants were grown in the presence of 1 mg/ml to 5 mg/ml sulfanilamide, and growth was measured after 18 h. The majority of modiﬁcation mutants
(yaaO, gsaB, ynbB, yfkA, and ywlG mutants) did not display the same sulfanilamide
resistance seen in the efp mutant (Fig. 4A). The exception was the ymfI mutant, which

TABLE 2 Growth conditions where the WT displayed enhanced respiration
Mode of action
pH 4.5
Toxic ion
Chelator
Protein synthesis
Nitro compound
DNA topoisomerase
Toxicity
Osmotic sensitivity
Bioﬁlm inhibitor
Cell wall
Respiration
March/April 2018 Volume 9 Issue 2 e00306-18

No. of hits
19
14
5
4
4
3
3
3
3
2
2
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TABLE 3 Growth conditions where the efp mutant displayed enhanced respiration
Mode of action
Folate antagonist
Oxidizing agent
Protein synthesis
Cell wall

No. of hits
9
2
1
1

was somewhat resistant to sulfanilamide, though not to the full extent of the efp
mutant (Fig. 4A).
In addition to sulfonamide resistance, the efp mutant also displayed enhanced
respiration in the presence of puromycin, a translation inhibitor that results in premature termination of polypeptide synthesis (Table 3 and Table S2). To determine whether
puromycin sensitivity is impacted by the EF-P modiﬁcation state, all modiﬁcation
mutants were grown in the presence of 1 g/ml to 20 g/ml puromycin, and growth
was measured after 8 h. In contrast to the sulfanilamide phenotype, the majority of
modiﬁcation mutants (yaaO, gsaB, ynbB, and ymfI mutants) phenocopied the efp
mutant, while both the ywlG and yfkA mutants were sensitive to puromycin treatment
as in the case of the wild-type strain (Fig. 4B).
Altered EF-P modiﬁcation state has variable impact on polyproline translation.
In previously characterized instances of EF-P PTM, EF-P has been shown to require
modiﬁcation for activity, and PTM mutants display phenotypic characteristics similar to
those of efp mutants (15, 20, 21). Here, phenotypic characterization of the PTM mutants
has revealed an apparent discrepancy between the requirement for EF-P itself and the
requirement for EF-P modiﬁcation. One way to explain the discrepancy is if each of the

FIG 4 Antibiotic sensitivity in efp and PTM mutants. WT (DK1042), efp (DK2050), yfkA (DK4564), ywlG
(DK4612), yaaO (DK3894), gsaB (DK4601), ynbB (DK4604), and ymfI (DK3621) strains were grown in the
presence of the indicated amount of 2 mg/ml sulfanilamide (A) or 15 g/ml puromycin (B), and the ﬁnal
OD600 was measured after 18 h (A) or 8 h (B) of growth.
March/April 2018 Volume 9 Issue 2 e00306-18

mbio.asm.org 8

EF-P PTM in B. subtilis

®

FIG 5 A GFP (A), PPW-GFP (B), PPP-GFP (C), or PPE-GFP (D) reporter construct was chromosomally inserted into
amyE in each mutant (Rajkovic et al. [22]). After a 1-h induction with 1 mM IPTG, GFP ﬂuorescence was measured.
Fluorescence levels were normalized to OD600. Values are means ⫾ standard deviations (SD) (error bars) from three
biological replicates. Statistical signiﬁcance was determined with an analysis of variance (ANOVA) and Tukey
posthoc test (*, P ⬍ 0.05; **, P ⬍ 0.01). (E) Ratio of WT/mutant for each PPX-GFP reporter in each mutant
background.

PTM mutants has variation in polyproline translation defects. In order to address this
possibility, all mutants were transformed with a polyproline-green ﬂuorescent protein
(GFP) reporter construct containing one of three polyproline motifs (PPP, PPW, and PPE)
(22). In the absence of ywlG, there was no signiﬁcant defect in polyproline translation
for any motif (Fig. 5B to D). In contrast, mutants that lacked gsaB, ynbB, or yaaO
displayed signiﬁcant polyproline translation defects for all three polyproline motifs,
although this defect was not as signiﬁcant as the defect seen in an efp mutant (Fig. 5B
to D). Loss of ymfI or yfkA has variable impact on polyproline translation. In the ymfI
mutant, there is no signiﬁcant decrease in PPW-GFP levels, whereas there is a signiﬁcant
decrease in PPP-GFP and PPE-GFP levels (Fig. 5B to D). In the yfkA mutant, there is a
small defect in PPW-GFP levels and more signiﬁcant decrease in PPP-GFP and PPE-GFP
March/April 2018 Volume 9 Issue 2 e00306-18
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levels. It is also noteworthy that while there is a decrease in polyproline translation
efﬁciency for the ymfI and yfkA mutants, it is less severe than for gsaB, ynbB, and yaaO
mutants.
To characterize the relative severity of the polyproline translational defect for each
motif, the average PPX-GFP ﬂuorescence in the wild-type strain was compared to each
mutant (Fig. 5E). Consistent with previous studies, PPW-GFP displayed the highest EF-P
dependence in the efp mutant (5, 22). In contrast, in each of the PTM mutants, PPP-GFP
displayed the highest EF-P dependence. Each PTM mutant also displayed variability in
the relative EF-P dependence for each motif. Many mutants exhibited a more signiﬁcant
defect in PPW translation than in PPE translation, but in the case of ymfI and ywlG, the
translational defects with both of these motifs were essentially indistinguishable. This
indicates that modulation of EF-P modiﬁcation state not only impacts the strength of
EF-P-dependent pausing, but it also alters the context dependence of EF-P-dependent
pausing.
DISCUSSION
EF-P is modiﬁed through multistep assembly that is reminiscent of FAB. In order
to efﬁciently stimulate translation of polyproline motifs, EF-P requires PTM of a conserved residue. In Gram-negative bacteria and eukaryotes, several diverse modiﬁcations
have been identiﬁed, and the enzymes that facilitate modiﬁcation are known. Recently,
a novel EF-P PTM has been identiﬁed in the Gram-positive bacterium B. subtilis, but
many of the genes required for modiﬁcation have remained unknown (22). Mass
spectrometry analyses revealed that intermediate modiﬁcations (5-aminopentanone, hydroxypentanone, pentenone, and acetylation) have been detected on Lys32 in WT and
modiﬁcation-deﬁcient samples. On the basis of the intermediates identiﬁed, we propose an
outline for EF-P PTM in B. subtilis (Fig. 3). It should be noted that intermediates would not
have be detected in this study if they were unstable or rapidly turned over. Therefore,
additional intermediates in the pathway cannot be excluded. Nevertheless, our results
indicate that B. subtilis employs a novel multistep method of modiﬁcation that produces
intermediates with distinct similarities to those found in FAB (Fig. 3). Although
5-aminopentanolylation does appear to be derived from FAB, genetic manipulation of FAB
did not impact the isoelectric focusing point of EF-P (Fig. S5). This could indicate that the
two processes are not biologically linked. It is also likely that the metabolic burden that EF-P
modiﬁcation imposes on the cell is minor compared to that of FAB. Therefore, altering the
levels of several FAB factors would not be sufﬁcient to impact the overall EF-P modiﬁcation
substrate pool to the point that changes in EF-P modiﬁcation status could be readily
observed.
Several of the intermediates identiﬁed here were not detected in previous studies,
possibly because in this study EF-P-FLAG was puriﬁed using milder puriﬁcation conditions to help with the detection of less stable intermediates. Furthermore, in our mass
spectrometry procedure, the top 10 most abundant ions from each cycle were selected
for MS/MS. In previous studies, only the top four were selected. Together, these
differences in methodology allowed for the detection of ions and thus corresponding
intermediates that would be less stable or present at much lower abundance.
5-Aminopentanolylation as an EF-P modiﬁcation strategy in other organisms.
Here, we employed a forward genetic screen to identify genes required for 5-aminopentanolylation of EF-P. In order to predict which other bacteria modify EF-P with
5-aminopentanol, we searched for organisms that maintain all of the ymfI, yaaO, gsaB,
ynbB, yfkA, and ywlG genes. Although many bacteria contained at least one of the
modiﬁcation genes, organisms that maintain the entire core set of modiﬁcation genes
could be found only within Firmicutes (Fig. 6). A number of proteobacteria also appear to
maintain the core set of 5-aminopentanolylation genes. As these species also contain the
machinery for R-␤-lysylation, it is unlikely that 5-aminopentanolylation is the EF-P modiﬁcation strategy for these organisms. This result instead likely stems from the fact that the
genes required for 5-aminopentanol assembly are homologous to other broadly conserved
genes.
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FIG 6 Phylogenetic tree predicting other bacteria that will employ 5-aminopentanolylation as a modiﬁcation strategy. Organisms that maintain ymfI, ynbB,
gsaB, yfkA, ywlG, and yaaO are indicated in blue. Phylogenetic classiﬁcations are marked by the corresponding colors in the color key. The taxonomic tree was
generated using iTol.

EF-P-dependent pausing is variably impacted by altered modiﬁcation state. In
all known instances of EF-P and eIF5A PTM, EF-P requires modiﬁcation for function, and
PTM mutants essentially phenocopy efp mutants (15–17, 20). Conversely in B. subtilis,
there is substantial phenotypic variability between the efp mutant and each PTM
mutant. The complete 5-aminopentanol PTM is required for puromycin sensitivity, but
it is dispensable for swarming motility and sulfanilamide sensitivity in the majority of
the PTM mutants. In vivo polyproline reporter data indicate that each mutant displays
a context-dependent defect in polyproline translation, with each motif being impacted
unequally by the altered modiﬁcation state of EF-P. This result likely accounts for the
phenotypic variability observed between the efp mutant and the PTM mutants. It is of
note that the majority of the modiﬁcation mutants displayed a polyproline translation
defect equal to or more severe than the defect of the ymfI mutant, yet they restored
swarming to the ymfI mutant in the initial screen. This result suggested that PPP, PPE,
and PPW are not relevant motifs for swarming proﬁciency. Of the proteins that are
known to be required for motility, 23 contain polyproline motifs, with 13 different PPX
motifs distributed among the proteins (22). It is likely that in the absence of ymfI, there
is a signiﬁcant polyproline translation defect in one of these other EF-P-dependent
proteins, resulting in the swarming defect that can be alleviated by blocking 5-aminopentanone
formation.
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It has recently been established that in the case of R-␤-lysylated EF-P, the modiﬁcation interacts with the CCA end of the p-site tRNA, stabilizing it in a conformation that
is favorable for peptide bond formation (11). Here, we have shown that alteration of
EF-P modiﬁcation not only decreases polyproline translation efﬁciency but also modulates the relative impact that EF-P has on each PPX motif. This result suggests that the
relative EF-P dependence of each PPX motif is directly impacted by the nature of the
modiﬁcation itself. It would therefore be expected that organisms with a high content
in a speciﬁc PPX motif would require a modiﬁcation suited for a stabilizing conformation for that motif, perhaps justifying the structural diversity found in all known EF-P
PTMs. Ribosomal proﬁling in organisms that employ alternative modiﬁcation strategies
will be required to directly address this possibility.
While EF-P modiﬁcation is critical for efﬁcient polyproline translation, both the
structure and source of the modiﬁcation are variable between organisms. This speaks
to the nature of EF-P posttranslational modiﬁcation, in that although modiﬁcations are
structurally diverse, they may all be simply siphoned out of natural metabolic processes. Through this work, we have expanded the possible metabolic sources for EF-P
PTM and have shown how alteration of this modiﬁcation modulates EF-P activity.
MATERIALS AND METHODS
Growth conditions and strain construction. Strains were grown in Luria broth (LB) (5 g NaCl, 5 g
yeast extract, 10 g tryptone [all per liter]) with 100 g/ml spectinomycin, 12.5 g/ml tetracycline,
0.5 g/ml erythromycin, 5 g/ml chloramphenicol, 5 g/ml kanamycin, 1 g/ml erythromycin plus
25 g/ml lincomycin (for macrolide-lincomycin-streptogramin B [MLS] resistance), and 100 g/ml
ampicillin when appropriate.
In-frame deletions. (i) ⌬yaaO. Bacillus subtilis 3610 genomic DNA was PCR ampliﬁed using primers
4933/4934 and 4935/4936. The resulting fragments were inserted into the SmaI restriction site of
pMiniMAD2 using Gibson assembly to create pKRH58. pKRH58 was passaged through the recA⫹
Escherichia coli strain TG1 and subsequently transformed into strain DK1042 or DK4601. pMiniMAD2
encodes MLS resistance and a temperature-sensitive origin of replication that is active at room temperature, but not at 37°C. Thus, colonies that integrated the plasmid into their genome were selected for by
growth in the presence of MLS at 37°C. Plasmid eviction was promoted by inducing the temperaturesensitive origin through overnight growth at room temperature. The resulting MLS-sensitive colonies
were isolated and conﬁrmed to carry the deletion by PCR-length polymorphism analysis to create strains
DK3894 (ΔyaaO) and DK4750 (ΔgsaB ΔyaaO). The transposon from strain DK4300 was transduced into
DK1042 to produce DK4325.
(ii) ⌬yfkA. B. subtilis 3610 genomic DNA was PCR ampliﬁed using primers 5279/5281 and 5280/5282.
The resulting fragments were inserted into the SmaI restriction site of pMiniMAD2 using Gibson assembly
to create pKRH69. pKRH69 was passaged through the recA⫹ E. coli strain TG1 and subsequently
transformed into strain DK1042. MLS-resistant colonies were isolated at 37°C, and plasmid eviction was
promoted by overnight growth at room temperature. The resulting MLS-sensitive colonies were isolated
and conﬁrmed to carry the deletion by PCR-length polymorphism analysis to create strain DK4564. The
ymfI::tet mutation was transduced into strain DK4564 to produce DK5170. The transposon from strain
DK4303 was transduced into DK1042 to produce DK4555.
(iii) ⌬ynbB. B. subtilis 3610 genomic DNA was PCR ampliﬁed using primers 5283/5284 and 5285/
5286. The resulting fragments were inserted into the SmaI restriction site of pMiniMAD2 using Gibson
assembly to create pKRH70. pKRH70 was passaged through the recA⫹ E. coli strain TG1 and subsequently
transformed into strain DK1042. MLS-resistant colonies were isolated at 37°C, and plasmid eviction was
promoted by overnight growth at room temperature. The resulting MLS-sensitive colonies were isolated
and conﬁrmed to carry the deletion by PCR-length polymorphism analysis to create strain DK4604. The
ymfI::tet mutation was transduced into strain DK4604 to produce DK5172. The transposon from strain
DK4381 was transduced into DK1042 to produce DK4389.
(iv) ⌬ynbA. B. subtilis 3610 genomic DNA was PCR ampliﬁed using primers 5287/5288 and 5289/
5290. The resulting fragments were inserted into the SmaI restriction site of pMiniMAD2 using Gibson
assembly to create pKRH71. pKRH71 was passaged through the recA⫹ E. coli strain TG1 and subsequently
transformed into strain DK1042. MLS-resistant colonies were isolated at 37°C, and plasmid eviction was
promoted by overnight growth at room temperature. The resulting MLS-sensitive colonies were isolated
and conﬁrmed to carry the deletion by PCR-length polymorphism analysis to create strain DK4605. The
ymfI::tet mutation was transduced into strain DK4605 to produce DK5173.
(v) ⌬gsaB. B. subtilis 3610 genomic DNA was PCR ampliﬁed using primers 5291/5292 and 5293/5294.
The resulting fragments were inserted into the SmaI restriction site of pMiniMAD2 using Gibson assembly
to create pKRH72. pKRH72 was passaged through the recA⫹ E. coli strain TG1 and subsequently
transformed into strain DK1042. MLS-resistant colonies were isolated at 37°C, and plasmid eviction was
promoted by overnight growth at room temperature. The resulting MLS-sensitive colonies were isolated
and conﬁrmed to carry the deletion by PCR-length polymorphism analysis to create strain DK4601. The
ymfI::tet mutation was transduced into strain DK4601 to produce DK5171. The transposon from strain
DK4375 was transduced into DK1042 to produce DK4554.
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(vi) ⌬ywlG. B. subtilis 3610 genomic DNA was PCR ampliﬁed using primers 5295/5296 and 5297/5298.
The resulting fragments were inserted into the SmaI restriction site of pMiniMAD2 using Gibson assembly
to create pKRH73. pKRH73 was passaged through the recA⫹ Escherichia coli strain TG1 and subsequently
transformed into strain DK1042. MLS-resistant colonies were isolated at 37°C, and plasmid eviction was
promoted by overnight growth at room temperature. The resulting MLS-sensitive colonies were isolated
and conﬁrmed to carry the deletion by PCR-length polymorphism analysis to create strain DK4612. The
ymfI::tet mutation was transduced into strain DK4601 to produce DK5174. The transposon from strain
DK4368 was transduced into DK1042 to produce DK4556.
EF-P-FLAG expression strains. To create the yaaO efp-ﬂag strain, the efp::tet mutation from strain
DS354 was transduced into strain DK3894, and the amyE::Physpank-efp-ﬂag construct from strain DK2448
was transduced into the resulting strain to create DK3908. To create the yfkA efp-ﬂag strain, the efp::tet
mutation from strain DS354 was transduced into DK4564, and the amyE::Physpank-efp-ﬂag construct from
DK2448 was transduced into the resulting strain to create DK4572. To create the gsaB yaaO efp-ﬂag strain,
the efp::tet mutation from strain DS354 was transduced into DK4750, and the amyE::Physpank-efp-ﬂag
construct from DK2448 was transduced into the resulting strain to create DK4815. The ynbB, gsaB, and
ywlG efp-ﬂag strains were created by transducing the transposons from strains DK4301, DK4304, and
DK4368 into strain DK2448 to create DK4310, DK4313, and DK4573, respectively.
Complementation constructs. (i) PynbA-ynbB. The ynbA promoter was ampliﬁed using primers
5877/5878, and the ynbB open reading frame was ampliﬁed using primers 5879/5880 from B. subtilis 3610
genomic DNA. The ynbA and ynbB fragments were digested with HindIII/NheI and NheI/SphI, respectively, and ligated into the HindIII/SphI sites of pAH25 to create pKRH86. pKRH86 was transformed into
strain DK4604 to create DK5321, and the ymfI::tet mutation from strain DS235 was transduced into
DK5309 to create DK5321.
(ii) PyfkA-yfkA. The yfkA promoter and open reading frame were ampliﬁed using primers 5881/5882 from
B. subtilis 3610 genomic DNA. The resulting fragment was digested with BamHI/NheI and ligated into the
BamHI/NheI sites of pAH25 to create pKRH87. pKRH87 was transformed into strain DK4564 to create DK5165,
and the ymfI::tet mutation from strain DS235 was transduced into DK5165 to create DK5304.
(iii) PynbA-ynbB. The ywlF promoter was ampliﬁed using primers 5883/5884, and the ywlG open
reading frame was ampliﬁed using primers 5879/5880 from B. subtilis 3610 genomic DNA. The ywlF and
ywlG fragments were digested with HindIII/NheI and NheI/EcoRI, respectively, and ligated into the
HindIII/EcoRI sites of pAH25 to create pKRH88. pKRH88 was transformed into strain DK4612 to create
DK5166, and the ymfI::tet mutation from strain DS235 was transduced into DK5166 to create DK5326.
(iv) PxpcA-yaaO. The xpcA promoter was ampliﬁed using primers 5887/5888, and the yaaO open
reading frame was ampliﬁed using primers 5889/5890 from B. subtilis 3610 genomic DNA. The xpcA and
yaaO fragments were digested with HindIII/NheI and NheI/SphI, respectively, and ligated into the
HindIII/SphI sites of pAH25 to create pKRH89. pKRH89 was transformed into strain DK3894 to create
DK5167, and the ymfI::tet mutation from strain DS235 was transduced into DK5167 to create DK5305.
(v) PgsaB-gsaB. The gsaB promoter and open reading frame were ampliﬁed using primers 5909/5946
from B. subtilis 3610 genomic DNA. The resulting fragment was digested with BamHI/NheI and ligated
into the BamHI/NheI sites of pAH25 to create pKRH90. pKRH90 was transformed into strain DK4601 to
create DK5308, and the ymfI::tet mutation from strain DS235 was transduced into DK5308 to create
DK5320.
(vi) Physpank-yaaO. The yaaO open reading frame was excised from pKRH89 by restriction digestion
with NheI/SphI and ligated into the NheI/SphI restriction sites of pDR111 to create pKRH112. pKRH112
was then transformed into strains DK3894 and DK4077 to create DK5327 and DK5328, respectively.
PPX-GFP reporter strains. (i) amyE::Physpank-gfp. pAW92 was transformed into strains DK1042,
DK2050, DK4601, DK4604, DK4564, DK4612, DK3621, and DK3894 to create strains AW112, AW114,
AW118, AW120, AW122, AW124, RT01, and RT03, respectively (22).
(ii) amyE::Physpank-ppw-gfp. pAW40 was transformed into strains DK1042, DK2050, DK4601, DK4604,
DK4564, DK4612, DK3621, and DK3894 to create strains AW113, AW115, AW119, AW121, AW123, AW125,
RT02, and RT04, respectively (22).
(iii) amyE::Physpank-ppp-gfp. pAW93 was transformed into strains DK1042, DK2050, DK3621, DK3894,
DK4601, DK4604, DK4564, and DK4612 to create strains AW149, AW150, AW156, AW157, AW158, AW159,
AW160, and AW161, respectively (22).
(iv) amyE::Physpank-ppe-gfp. ppe-gfp was ampliﬁed from pAW93 using primers 1657/7514. The
resulting fragment was ligated into SphI/NheI-digested pDR111 using Gibson assembly to generate
pAW162. pAW162 was transformed into strains DK1042, DK2050, DK3621, DK3894, DK4601, DK4604,
DK4564, and DK4612 to create strains AW163, AW164, AW165, AW166, AW167, AW168, AW169, and
AW170, respectively.
FAB overexpression strains. (i) amyE::Physpank-fabF. fabF was ampliﬁed from B. subtilis 3610
genomic DNA using primers 6102/6103. The resulting fragment was ligated into SphI/NheI-digested
pDR111 using Gibson assembly to generate pAW143. pAW143 was transformed into strain DK1042 to
generate strain AW146.
(ii) amyE::Physpank-fabG. fabG was ampliﬁed from B. subtilis 3610 genomic DNA using primers
6104/6105. The resulting fragment was ligated into SphI/NheI-digested pDR111 using Gibson assembly
to generate pAW144. pAW144 was transformed into strain DK1042 to generate strain AW147.
(iii) amyE::Physpank-fabG. fabG was ampliﬁed from B. subtilis 3610 genomic DNA using primers
6106/6107. The resulting fragment was ligated into SphI/NheI-digested pDR111 using Gibson assembly
to generate pAW145. pAW145 was transformed into strain DK1042 to generate strain AW148.
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YmfI suppressor screen. Transposon delivery vectors for TnYLB and TnHyJump were introduced
into the nonswarming, sensitized ymfI mutant background DK3789 by SPP1-mediated phage transduction followed by selection for MLS resistance at room temperature. Both delivery vectors contain a
transposon encoding a kanamycin resistance cassette and a temperature-sensitive origin that allows for
replication at room temperature but not 42°C in B. subtilis (26, 27). The resulting colonies were used to
inoculate 26 separate 3-ml LB cultures, and transposon mutagenesis was allowed to occur by incubation
at room temperature overnight. Mutants with transposon insertions in the genome were selected by
incubating cells at 42°C on LB plates containing kanamycin. Approximately 10,000 of the resulting
colonies from each pool were combined, and each pool was used to inoculate separate swarming
motility agar plates. Following a 7- to 10-h incubation at 37°C, swarming proﬁcient mutants emerged
from the site of inoculation as a disk of motile cells, colonies were isolated, and the transposon was
backcrossed to verify that suppression of ymfI was inseparably linked to the transposon insertion.
To determine the locations of the transposon insertion sites, genomic DNA was isolated from each
backcrossed suppressor strain, digested with either Sau3A1 or TaqA1 restriction enzymes, and ligated
using T4 ligase to create circular fragments. Primer pairs 695/696 and 2567/2818, which anneal to TnYLB
and TnHyJump, respectively, and direct polymerization outwards from the transposon was used to PCR
amplify the neighboring DNA. The resulting DNA fragments were subsequently sequenced with primers
696 and 2567, respectively, to determine the transposon insertion site.
Swarming motility assay. Cells were grown to mid-logarithmic phase in LB at 37°C and concentrated to an optical density at 600 nm (OD600) of 10 in phosphate-buffered saline (PBS) (pH 7.4) (0.8%
NaCl, 0.02% KCl, 100 mM Na2HPO4, and 17.5 mM KH2PO4) plus 0.5% India ink. Cell suspensions were used
to centrally inoculate 0.7% agar LB plates that had been dried for 10 min open-faced in a laminar ﬂow
hood. Swarm plates were dried an additional 12 min after inoculation. The plates were incubated at 37°C.
and swarm radius was monitored along the same axis every 30 min for 5.5 h.
Isoelectric focusing. Strains were grown in 5 ml LB at 37°C with shaking. When the cultures had
reached mid-log phase, the cells were collected and lysed in 25 l lysis buffer (10% glycerol, 25 mM Tris
[pH 7.4], 100 mM NaCl, cOmplete mini EDTA-free protease inhibitor tablet [Roche], 1 mg/ml lysozyme, 1.5
U of DNase I). Isoelectric focusing gels were prepared as previously described, with an ampholyte range
of 4.0 to 6.5 (Rajkovic et al. [22]). Prior to sample loading, the isoelectric focusing gel was prefocused at
100 V for 45 min. Following sample loading, the bands were resolved at 200 V for 1 h, 300 V for 1 h, and
500 V for 30 min. The gels were soaked in Towbin buffer for 15 min and then transferred to nitrocellulose
paper for Western blotting. Blotting was completed with a 1:40,000 dilution of anti-EF-P polyclonal
antisera primary antibody and 1:5,000 dilution of goat anti-rabbit conjugated to horseradish peroxidase
secondary antibody. Blots were developed with Bio-Rad Clarity ECL substrate.
Seminative gel electrophoresis. Strains were grown to mid-log phase, concentrated to an OD600 of 10
in lysis buffer (17.2 mM Tris [pH 7.0], 8.6 mM EDTA [pH 8.0], 1 mg/ml lysozyme, 0.1 mg/ml RNase A, 20 g/ml
DNase I, and 50 g/ml phenylmethane sulfonyl ﬂuoride) and incubated at 37°C for 30 min. SDS sample buffer
(500 mM Tris [pH 6.8], 22% glycerol, 10% SDS, and 0.12% bromophenol blue) was added, and samples were
boiled for 5 min. The 12-l boiled samples were loaded onto 10% polyacrylamide native (with no added SDS)
or 15% polyacrylamide denaturing (with 0.1% SDS) gels. The lysates were resolved at 150 V for 1.25 h,
transferred onto nitrocellulose membranes, and subsequently probed with a 1:40,000 dilution of anti-EF-P or
a 1:80,000 dilution anti-SigA polyclonal antiserum. Following incubation with the primary antibodies, nitrocellulose membranes were probed with horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin
G. Blots were developed using Pierce ECL substrate (Thermo Fisher Scientiﬁc).
Mass spectrometry. EF-P-Flag was puriﬁed from strains DK2448, DK4313, DK4310, DK4572, DK4573,
and DK3908. Saturated overnight cultures were back diluted 1:1,000 in 1.5 liters of LB. When cultures
reached mid-log phase, EF-P-Flag expression was induced with 1 mM IPTG for 3 h. The cells were then
collected and lysed in 5 ml lysis buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1 mg/ml lysozyme, cOmplete
mini EDTA-free protease inhibitor tablet [Roche]) for 1 h at 37°C. EF-P-Flag was puriﬁed with anti-ﬂag M2
magnetic beads (Sigma-Aldrich) at 4°C, following the manufacturer’s instructions with minor alterations.
EF-P was eluted with 100 g/ml ﬂag peptide (Sigma-Aldrich), concentrated, and resolved on a 13%
SDS-polyacrylamide gel. Bands were visualized with colloidal Coomassie blue stain and excised for in-gel
digestion with trypsin.
For strains DK2448, DK4313, DK4310, DK4572, and DK4573, the generated peptide samples were
brought up in 2% acetonitrile in 0.1% formic acid (20 l) and analyzed (2 l) by liquid chromatographyelectrospray ionization-tandem mass spectrometry (LC/ESI MS/MS) with a Thermo Scientiﬁc Easy-nLC II
system (Thermo Fisher Scientiﬁc, Waltham, MA) coupled to a hybrid Orbitrap Elite ETD (Thermo Fisher
Scientiﬁc, Waltham, MA) mass spectrometer. In-line desalting was accomplished using a reversed-phase
trap column (100 m by 20 mm) packed with Magic C18AQ (5-m 200-Å resin; Michrom Bioresources,
Auburn, CA) followed by peptide separations on a reversed-phase column (75 m by 250 mm) packed
with Magic C18AQ (5-m 100-Å resin; Michrom Bioresources, Auburn, CA) directly mounted on the
electrospray ion source. A 40-min gradient from 2% to 40% acetonitrile in 0.1% formic acid at a ﬂow rate
of 400 nl/min was used for chromatographic separations. A spray voltage of 2,750 V was applied to the
electrospray tip, and the Orbitrap Elite instrument was operated in the data-dependent mode, switching
automatically between MS survey scans in the Orbitrap (AGC target value, 1,000,000; resolution, 120,000;
injection time, 250 ms) with MS/MS spectra detected in the Orbitrap (AGC target value, 50,000;
resolution, 15,000; injection time, 250 ms). The 10 most intense ions from the Fourier transform (FT) full
scan were selected for fragmentation in the Orbitrap using electron transfer dissociation (ETD) 100-ms
activation time with supplemental collision-induced dissociation (CID) activation with normalized collision energy of 35%. Selected ions were dynamically excluded for 10 s.
March/April 2018 Volume 9 Issue 2 e00306-18

mbio.asm.org 14

EF-P PTM in B. subtilis

®

For strains DK2448 and DK3908, the generated peptide samples were brought up in 2% acetonitrile
in 0.1% formic acid (20 l) and analyzed (2 l) by LC/ESI MS/MS with a Thermo Scientiﬁc Easy-nLC II
(Thermo Fisher Scientiﬁc, Waltham, MA) coupled to a hybrid Orbitrap Fusion (Thermo Fisher Scientiﬁc,
Waltham, MA) mass spectrometer. The peptides were separated on a reversed-phase column (75 m by
370 mm) packed with Magic C18AQ (5-m 100-Å resin; Michrom Bioresources, Auburn, CA) directly
mounted on the electrospray ion source. A 40-min gradient from 2% to 40% acetonitrile in 0.1% formic
acid at a ﬂow rate of 300 nl/min was used for chromatographic separations. A spray voltage of 2,100 V
was applied to the electrospray tip, and the Orbitrap Fusion instrument was operated in the datadependent mode, switching automatically between MS survey scans in the Orbitrap (AGC target value,
400,000; resolution, 120,000; injection time, 50 ms) with MS/MS spectra detected in the Orbitrap (AGC
target value, 50,000; resolution, 15,000 resolution; injection time, 22 ms). The 10 most intense ions from
the Fourier transform (FT) full scan were selected for fragmentation in the Orbitrap using ETD chargedependent activation time with CID activation with normalized collision energy of 35%. Selected ions
were dynamically excluded for 10 s. Modiﬁcations detected when strain DK2448 was analyzed on the
Orbitrap Fusion were the same as modiﬁcations detected when analyzed on the Orbitrap Elite ETD.
MS/MS data are presented only for strain DK2448 analyzed on the Orbitrap Elite ETD, though both data
sets are available upon request (Fig. S3J to L). For all samples, peptides were mapped using Proteome
Discoverer (Thermo Fisher Scientiﬁc).
GFP reporter assay. Saturated overnight cultures were back diluted 1:1,000 in LB with 100 g/ml
spectinomycin and grown at 37°C with shaking. When cultures reached mid-log phase, GFP expression
was induced with 1 mM IPTG for 1 h. Following induction, 1 ml of cells was collected from each culture
and washed once in PBS. Fluorescence was then measured with a Horiba Fluorlog spectroﬂuorimeter.
Phenotype microarray. Respiration of the wild-type (WT) (DK1042) and efp mutant (DK2050) strains
were compared in the Biolog microbial plates PM1-20 according to the manufacturer’s instructions. Both
strains were grown on BUG⫹B agar plates overnight and then subcultured a second time. Cells were
collected from plates and suspended in IF-0a Biolog media to an optical density (OD) of 0.09. Cells
were mixed with inoculating ﬂuid additives where appropriate and aliquoted into wells. The plates were
incubated in the OmniLog PM System at 37°C for 24 h, with readings taken every hour.
Antibiotic sensitivity assay. Overnight saturated cultures were back diluted to an OD600 of 0.01 in LB
with 0 to 5 mg/ml sulfanilamide or 0 to 20 g/ml puromycin. The cultures were grown at 37°C with shaking
for 18 h or 8 h, respectively. The optical density of each culture was measured after the indicated length of
time.
Phylogenetic analysis. From the GenBank assembly summary ﬁle, we obtained faa ﬁles of all
bacteria known to have their complete genomes sequenced. The removal of duplicate entries yielded a
total of 4,196 genomes from which we built a BLAST database using the NCBI-BLAST-2.3.0⫹ software
(28). The B. subtilis 168 genes efp, yaaO, ymfI, ynbB, gsaB, yfkA, and ywlG were independently subjected
to a BLAST search against the database with an arbitrary E value of 0.001 selected to be the cutoff. The
exclusive presence of efp (with a lysine at position 32 or analogous to position 32), yaaO, ymfI, and ynbB
were plotted across a taxonomic tree generated using ITOL (29). Access to the taxonomic tree can be
found at the following web address: http://itol.embl.de/tree/13023848185272891498208300.
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